If the pharmaceutical company does the research, it'll be a trade secret, and they won't have to share with anyone, and they won't, not till they get all their patents in place, and they'll be able to charge whatever they want.
Si la compañía hace la investigación será un secreto comercial y no tendrán que compartirlo con nadie. Y no lo harán hasta tener todas sus patentes. Y podrán cobrar lo que quieran.